| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615885 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 6 Pages |
Abstract
CLAG plus IM was well tolerated, with encouraging signs of activity in patients with poor-risk AML.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Abu-Sayeef Mirza, Jeffrey E. Lancet, Kendra Sweet, Eric Padron, Javier Pinilla-Ibarz, Lisa Nardelli, Christopher Cubitt, Alan F. List, Rami S. Komrokji,